High-Sensitivity Lipid Metabolism-Related Protein Assay and Diagnostic Reagent Development
First written in FY2017. 2 of 3 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2018-Q3.
No other company in this theme has enough history to compare yet.
- FY2018-Q3AdvancedAnnual report
「We also began selling kits capable of measuring LPL (lipoprotein lipase) and HTGL activity.」
Sales of activity measurement kits for LPL and HTGL began in the lipid metabolism-related measurement systems business. - FY2018-Q1AdvancedAnnual report
「We are pursuing joint development with Osaka University, Gunma University, Kobe University and others. As part of this work, we developed new improved versions of measurement kits for EL (endothelial lipase) and HTGL (hepatic triglyceride lipase), and began selling them as research-use reagents in May 2017. We also began selling a measurement kit for GPIHBP1, the protein presented in a research study at Gunma University on 6 April 2017, in May 2017.」
Sales of the improved EL and HTGL measurement kits and the GPIHBP1 measurement kit began in May 2017. - FY2017First statedAnnual report
「For molecules related to lipid metabolism, we are developing measurement systems for various lipases that regulate the breakdown of fat. We are also developing a measurement kit for GPIHBP1, a protein presented in a research study at Gunma University on 6 April 2017. We will continue this joint research with a view to developing these lipid metabolism-related proteins into in vitro diagnostic products.」
The company developed measurement systems for LPL, endothelial lipase, hepatic lipase, GPIHBP1 and other proteins, with a view to developing them from research-use reagents into in vitro diagnostic products.